BETHESDA, MD—With this year's flu season little more than an achy, sneezy memory, the Vaccine and Related Biological Products Advisory Committee has begun to select antigenic strains for the first influenza vaccine of the 21st century.
The committee has recommended retaining the current component of influenza A(H1N1), the strain known as A/Beijing/262/95, and has deferred a recommendation for A(H3N2) and the B strain.
Marwick C. Millennial Influenza Vaccine. JAMA. 1999;281(10):887–888. doi:10.1001/jama.281.10.887-JMN0310-5-1
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: